News ImmuCell Corporation

Equities

ICCC

US4525253062

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-18 pm EDT			5-day change	1st Jan Change
5.05 ^USD	0.00%		-1.56%	-0.79%

Apr. 09	Immucell Corporation Reports Unaudited Sales Results for the Three Months and Twelve Months Ended March 31, 2024	CI
Apr. 02	ImmuCell Shares Fall After $20 Million Mixed Securities Shelf Filing	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024	Apr. 09	AQ
Immucell Corporation Reports Unaudited Sales Results for the Three Months and Twelve Months Ended March 31, 2024	Apr. 09	CI
ImmuCell Shares Fall After $20 Million Mixed Securities Shelf Filing	Apr. 02	MT
Transcript : ImmuCell Corporation, Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023	Feb. 27	AQ
ImmuCell Corporation Enters into an Allonge to and Amendment of Line of Credit with Gorham Savings Bank	Feb. 27	CI
ImmuCell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
ImmuCell Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023	Feb. 16	AQ
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023	Jan. 08	AQ
ImmuCell Corporation Announces Unaudited Sales Results for the Fourth Quarter and Full Year Ended December 31, 2023	Jan. 08	CI
Transcript : ImmuCell Corporation, Q3 2023 Earnings Call, Nov 14, 2023	Nov. 14
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023	Nov. 13	AQ
ImmuCell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023	Nov. 07	AQ
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023	23-10-05	AQ
Immucell Corporation Reports Preliminary Unaudited Sales Results for the Third Quarter, Nine Months and Trailing Twelve Months Ended September 30, 2023	23-10-05	CI
ImmuCell Announces Submission of CMC Technical Section to the FDA	23-08-29	AQ
Transcript : ImmuCell Corporation, Q2 2023 Earnings Call, Aug 11, 2023	23-08-11
ImmuCell : August 2023 Corporate Presentation	23-08-10	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ImmuCell Corporation

Equities

ICCC

US4525253062

Summary

Filters